New blood test could extend prostate cancer survival
Intended for healthcare professionals
Journal scan Previous     Next

New blood test could extend prostate cancer survival

A three-in-one blood test could transform treatment of advanced prostate cancer through precision drugs targeting mutations in the BRCA genes.

Nursing Standard. 31, 46, 17-17. doi: 10.7748/ns.31.46.17.s19

Want to read more?

Already subscribed? Log in


Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now